Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

ExpreS2ion Biotech Holding AB (EXPRS2)

Stockholm
Currency in SEK
19.96
-0.89(-4.27%)
Closed
EXPRS2 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
18.6820.95
52 wk Range
0.8137.60
Key Statistics
Edit
Prev. Close
19.96
Open
20.85
Day's Range
18.68-20.95
52 wk Range
0.81-37.6
Volume
35.82K
Average Volume (3m)
317.4K
1-Year Change
1,213.16%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EXPRS2 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
303.00
Upside
+1,418.04%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

ExpreS2ion Biotech Holding AB Company Profile

ExpreS2ion Biotech Holding AB (publ), through its subsidiary, ExpreS2ion Biotechnologies ApS, researches and develops preventive and therapeutic vaccine products in the Nordics and internationally. The company’s lead asset is ES2B-C001, a therapeutic vaccine for breast cancer that targets the human epidermal growth factor receptor 2 receptor. It is also developing ES2B-I002, a cytomegalovirus vaccine candidate to treat infectious diseases. In addition, the company out licenses its ExpreS2 platform to research institutes and pharmaceutical companies. Further, it sells ExpreS2 test kits and reagents for research purposes or diagnostic applications. The company has collaboration agreement with University of Oxford for the development of vaccine for malaria; and Evaxion Biotech A/S for development of cytomegalovirus vaccine, as well as partnership agreement with Copenhagen University to develop vaccine for Influenza. The company operates an online store. ExpreS2ion Biotech Holding AB (publ) was incorporated in 2015 is based in Helsingborg, Sweden.

Employees
18
Market
Sweden

Compare EXPRS2 to Peers and Sector

Metrics to compare
EXPRS2
Peers
Sector
Relationship
P/E Ratio
−1.2x−1.3x−0.7x
PEG Ratio
−0.02−0.040.00
Price/Book
0.6x1.6x2.6x
Price / LTM Sales
5.3x8.6x3.2x
Upside (Analyst Target)
-114.5%43.2%
Fair Value Upside
Unlock24.9%6.8%Unlock

Analysts' Recommendations

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 303.00

(+1,418.04% Upside)

FAQ

What Is the ExpreS2ion Biotech (EXPRS2) Stock Price Today?

The ExpreS2ion Biotech stock price today is 19.96

What Stock Exchange Does ExpreS2ion Biotech Trade On?

ExpreS2ion Biotech is listed and trades on the Stockholm stock exchange.

What Is the Stock Symbol for ExpreS2ion Biotech?

The stock symbol for ExpreS2ion Biotech is "EXPRS2."

What Is the ExpreS2ion Biotech Market Cap?

As of today, ExpreS2ion Biotech market cap is 41.92M.

What is ExpreS2ion Biotech Earnings Per Share?

The ExpreS2ion Biotech EPS is -23.33.

What Is the Next ExpreS2ion Biotech Earnings Date?

ExpreS2ion Biotech will release its next earnings report on Feb 06, 2025.

From a Technical Analysis Perspective, Is EXPRS2 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.